Cardiac Rehabilitation for the Patients With Acute Myocardial Infarction
Launched by TAIPEI MEDICAL UNIVERSITY WANFANG HOSPITAL · Dec 14, 2022
Trial Information
Current as of January 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Cased diagnosed with acute myocardial infarction at emergent department and admitted
- • 2. Age over 20 years old
- Exclusion Criteria:
- • 1. AAD cases after admission to ER or the general ward
- • 2. Cases died within admission.
- • 3. Cases refused the treatments.-
Trial Officials
Shiauyee Chen, Master
Principal Investigator
Department of physical medicine and rehabilitation, Wan Fang Hospital
About Taipei Medical University Wanfang Hospital
Taipei Medical University Wan Fang Hospital is a leading healthcare institution in Taiwan, renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, the hospital combines cutting-edge medical technology with a multidisciplinary approach to research, facilitating innovative studies that address critical health challenges. With a focus on ethical standards and patient safety, Wan Fang Hospital collaborates with a network of medical professionals and researchers to contribute valuable insights to the global medical community. Its dedication to excellence in clinical trials underscores its role as a pivotal player in the advancement of healthcare practices and therapeutic developments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials